OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pen injectors, pull push fixed dose pens, and autoinjectors; sterile injectables; soft gelatin capsules; and biologics solutions for microbial and mammalian cell line biopharmaceuticals, cell and gene therapy, and RNA products. The company was formerly known as Stelis Biopharma Limited and changed its name to OneSource Specialty Pharma Limited in February 2024. OneSource Specialty Pharma Limited was incorporated in 2007 and is based in Bengaluru, India.
Low
1,057.00
High
1,925.00
Low
1,433.60
High
1,542.20
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How ONESOURCE SPECL PHARMA L stacks up against its Biotechnology peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ONESOURCE ONESOURCE SPECL PHARMA L | 1,500.00 | 1.42% | 0.00 | -4.25 | 17,201 | 2.02% | 19.01% | 1,925.00 / 1,057.00 |
| 2 | ANTHEM ANTHEM BIOSCIENCES LTD | 858.50 | 0.01% | 84.37 | 10.18 | 48,350 | 3.43% | 4.58% | 977.55 / 579.15 |
| 3 | BIOCON Biocon Limited | 371.40 | 0.30% | 109.95 | 3.38 | 60,495 | 9.61% | 5.14% | 447.15 / 337.70 |
| 4 | BLUEJET Blue Jet Healthcare Limited | 542.00 | 0.73% | 40.01 | 13.55 | 10,259 | 8.14% | 20.98% | 692.90 / 325.00 |
| 5 | CONCORDBIO Concord Biotech Limited | 1,399.00 | 1.85% | 53.18 | 26.31 | 14,636 | 10.15% | 17.41% | 1,667.60 / 987.00 |
| 6 | DCAL Dishman Carbogen Amcis Limited | 149.60 | 5.00% | 145.83 | 1.03 | 2,345 | 14.39% | 45.40% | 306.00 / 128.50 |
| 7 | PANACEABIO Panacea Biotec Limited | 358.50 | 2.05% | 0.00 | -1.16 | 2,196 | 11.81% | 8.24% | 647.00 / 292.40 |
| 8 | SUPRIYA Supriya Lifescience Limited | 925.00 | 2.66% | 0.00 | 0.00 | 7,489 | 16.04% | 41.22% | 1,085.00 / 545.50 |
| 9 | ZOTA Zota Health Care Limited | 1,253.10 | 3.21% | 0.00 | -30.88 | 4,340 | 15.29% | 5.57% | 1,740.00 / 1,022.00 |